<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2026-05-11T18:20:03.598Z</responseDate>
    <request verb="GetRecord" identifier="ezaposleni.singidunum.ac.rs/rest/sciNaucniRezultati/oai:2:9293" metadataPrefix="dim">http://ezaposleni.singidunum.ac.rs/rest/sciNaucniRezultati/oai</request>
    <GetRecord>
        <record>
            <header>
                <identifier>ezaposleni.singidunum.ac.rs/rest/sciNaucniRezultati/oai:2:9293</identifier>
                <datestamp>2023-03-07T14:54:12Z</datestamp>
                <setSpec>2</setSpec>
            </header>
            <metadata>
                <dim:dim>
                    <dim:field mdschema="dc" element="title" lang="en">Modulation of oxidative stress/antioxidative defence in human serum treated by four different tyrosine kinase inhibitors</dim:field>
                    <dim:field mdschema="dc" element="date" qualifier="issued">2020</dim:field>
                    <dim:field mdschema="dc" element="identifier" qualifier="uri">http://ezaposleni.singidunum.ac.rs/rest/sciNaucniRezultati/oai/record/2/9293</dim:field>
                    <dim:field mdschema="dc" element="contributor" qualifier="author" authority="id:40915" confidence="-1">M. Mihajlović</dim:field>
                    <dim:field mdschema="dc" element="contributor" qualifier="author" authority="id:40916" confidence="-1">B. Ivković</dim:field>
                    <dim:field mdschema="dc" element="contributor" qualifier="author" authority="id:40917" confidence="-1">B. Jančić Stojanović</dim:field>
                    <dim:field mdschema="dc" element="contributor" qualifier="author" authority="id:40918" confidence="-1">A. Zeljković</dim:field>
                    <dim:field mdschema="dc" element="contributor" qualifier="author" authority="id:40919" confidence="-1">V. Spasojević Kalimanovska</dim:field>
                    <dim:field mdschema="dc" element="contributor" qualifier="author" authority="id:40920" confidence="-1">J. Kotur Stevuljević</dim:field>
                    <dim:field mdschema="dc" element="contributor" qualifier="author" authority="orcid::0000-0001-8376-728X" confidence="-1">D. Vujanović</dim:field>
                    <dim:field mdschema="dc" element="type">article</dim:field>
                    <dim:field mdschema="dc" element="identifier" qualifier="doi">https://doi.org/10.1097/CAD.0000000000000924</dim:field>
                    <dim:field mdschema="dc" element="citation" qualifier="volume">31</dim:field>
                    <dim:field mdschema="dc" element="citation" qualifier="issue">9</dim:field>
                    <dim:field mdschema="dc" element="citation" qualifier="spage">942</dim:field>
                    <dim:field mdschema="dc" element="citation" qualifier="epage">949</dim:field>
                    <dim:field mdschema="dc" element="identifier" qualifier="issn">0959-4973</dim:field>
                    <dim:field mdschema="dc" element="source">ANTI-CANCER DRUGS</dim:field>
                </dim:dim>
            </metadata>
        </record>
    </GetRecord>
</OAI-PMH>
